Novartis India Limited (NIL) is a subsidiary of the Swiss pharmaceutical company Novartis. It primarily operates in manufacturing and marketing drugs across pharmaceuticals, generics, over-the-counter, and animal health products.

Novartis' history is marked by major mergers, starting with the merge of Ciba and Geigy in 1970, leading to the formation of Novartis in 1996 after Sandoz joined. This historical consolidation forms the backbone of their capabilities today.

The company has a strong CSR presence, having partnered with WHO on several health initiatives including malaria and tuberculosis efforts, which underscores their commitment to global health issues.

NIL has initiated several marketing strategies, including the 'Arogya Parivar' program targeting healthcare needs in rural India, highlighting their approach to differentiated healthcare solutions.

The company has engaged in strategic partnerships for distribution, notably with Nutri-Ad International for poultry feed supplements and Johnson & Johnson Limited for veterinary sutures, enhancing their product reach.